Press release
Atopic Dermatitis (AD) Market Analysis and Global Outlook 2021 to 2024 - Sanofi, Regeneron, Pfizer, Allergan
Atopic Dermatitis (AD) Market report provides an intricate analysis of market trends that shall affect the overall market. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market value and volume of the market. Moreover, the report offers insights on the current stature of key market players in the competitive landscape analysis of this market. The report also provides epidemiology and market forecast till 2024 with the impact of Novel COVID-19 pandemic on the market.The global Atopic Dermatitis (AD) Market was valued at USD 9.09 billion in the year 2018 and is projected to grow at a CAGR of around 11.0% during the forecast period.
Top Companies in the Global Atopic Dermatitis (AD) Market are
Sanofi, Regeneron, Pfizer, Allergan, Abbvie, Leo Pharma, Lilly, Aclaris, Anaptys Bio, Dermira, and Others.
This report elaborates the market size in USD Million, market characteristics, and market growth of the Atopic Dermatitis (AD) industry, and breaks it down according to the types of therapies and application, and consumption areas or avenues.
Click here to get a free latest sample copy of Atopic Dermatitis (AD) Market updated research 2021 before purchase
https://www.marketinsightsreports.com/reports/05202915799/global-atopic-dermatitis-ad-market-analysis-by-therapy-biologic-oral-topical-photo-end-user-pipeline-by-region-by-country-2020-edition-market-insight-competition-and-forecast-2019-2024/inquiry?mode=72&source=openPR
Atopic dermatitis (eczema) is a condition that makes your skin red and itchy. It's common in children but can occur at any age. Atopic dermatitis is long lasting (chronic) and tends to flare periodically. It may be accompanied by asthma or hay fever.
Types of the Atopic Dermatitis (AD) Market are
Biologic Therapy
Topical Therapy
Oral Therapy
Photo Therapy
Other
Applications of the Atopic Dermatitis (AD) Market are
Hospital
Clinics
Research Labs
Market News
- PARIS and TARRYTOWN, N.Y. / May 26, 2020 / FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is the only biologic medicine approved for this patient population…
For more information use referral link below
- NEW YORK / April 07, 2021 / Pfizer announces extension of review of new drug application of abrocitinib for the treatment of moderate to severe atopic dermatitis
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of adults and adolescents with moderate to severe atopic dermatitis…
For more information use referral link below
Browse Full Report Description with TOC
https://www.marketinsightsreports.com/reports/05202915799/global-atopic-dermatitis-ad-market-analysis-by-therapy-biologic-oral-topical-photo-end-user-pipeline-by-region-by-country-2020-edition-market-insight-competition-and-forecast-2019-2024?mode=72&source=openPR
Regions covered By Atopic Dermatitis (AD) Market Report 2021 To 2026 are
Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), North America (United States, Canada, and Mexico), Central & South America (Brazil, and Rest of South America), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other).
Objectives of the Atopic Dermatitis (AD) market report is
- A comprehensive evaluation of all opportunities and risks in the market.
- Atopic Dermatitis (AD) market current developments and significant occasions.
- The deep study of business techniques for the development of the market-driving players.
- Conclusive study about the improvement plot of market for approaching years.
- Top to bottom approach of market-express drivers, targets, and major littler scale markets.
Frequently Asked Questions about the Atopic Dermatitis (AD) market:
- What are the recent developments and government policies?
- What are the top trends in the Atopic Dermatitis (AD) market?
- What is the growth rate of the market?
- Which Is the Most potential market segment?
- Which are the top industry players in the Atopic Dermatitis (AD) market?
- Which region would offer high growth for vendors in the market?
References and Sources
https://www.sanofi.com/en/media-room/press-releases/2020/2020-05-26-17-40-00
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-extension-review-new-drug-application
Related Reports
Global Canine Atopic Dermatitis Treatment Industry https://www.marketinsightsreports.com/reports/05182894842/2016-2028-global-canine-atopic-dermatitis-treatment-industry-market-research-report-segment-by-player-type-application-marketing-channel-and-region?source=OpenPRR&mode=72
Oncology Drugs Global Market
https://www.marketinsightsreports.com/reports/12182507932/oncology-drugs-global-market-opportunities-and-strategies-to-2030-covid-19-impact-and-recovery-including-by-type-of-drug-lung-cancer-pancreatic-cancer-breast-cancer-prostate-cancer-ovarian-cancer-colorectal-cancer-gastric-cancer-kidney-cancer-brain-tumor-thyroid-cancer-skin-cancer-bladder-cancer-cervical-cancer-blood-cancer-others-by-drug-class-targeted-therapy-immunotherapy-biologic-therapy-chemotherapy-hormonal-therapy-by-distribution-channel-hospital-pharmacies-retail-pharmacies-drug-stores-others-by-route-of-administration-oral-parental-others-by-drug-classification-branded-drugs-generic-drugs-covering-novartis-ag-bristol-myers-squibb-company-merck-co-inc-johnson-johnson-pfizer-inc?mode=72&source=openPR
Free customization of the report: This report can be further customized according to the client’s specific requirements. No additional charges will be added for limited additional research.
Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States
Contact US :
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis (AD) Market Analysis and Global Outlook 2021 to 2024 - Sanofi, Regeneron, Pfizer, Allergan here
News-ID: 2294188 • Views: …
More Releases from Market Insights Reports
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world.
Some of the key players…
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
More Releases for Atopic
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
